No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
180 |
4. Check minimum number of eventsNone |
180 |
5. Include endpointsNone |
180 |
6. Filter based on genotype QC (FinnGen only) |
180 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F60
- Name in latin
- Personalitas histrionica
Similar endpoints
↥List of similar endpoints to
Histrionic personality disorder
based on the number of shared cases.
Similar with more cases:
- Specific personality disorders
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1630 | 1108 | 491 |
| Only index persons | 1208 | 870 | 338 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.01 |
| Only index persons | 0.03 | 0.03 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 37.99 | 39.56 | 33.95 |
| Only index persons | 35.62 | 37.32 | 31.25 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 180 | 130 | 50 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 30.85 | 30.04 | 32.95 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 166
- Matched controls
- 1662
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F60.4
ICD-10 Finland
Histrionic personality disorder
+∞
95.2
82
*
30150
ICD-8 Finland
Personality disorders, Hysterical
+∞
73.5
65
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
26.1
52.9
77
53
N05AH04
ATC
quetiapine; oral
14.9
47.9
93
130
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
+∞
41.4
38
*
N05AA02
ATC
levomepromazine; systemic
30.5
37.3
50
23
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
34.6
32
*
N05BA01
ATC
diazepam; systemic, rectal
10.0
32.1
73
120
N05AH03
ATC
olanzapine; systemic
17.4
31.3
51
41
T36
ICD-10 Finland
Poisoning by systemic antibiotics
23.3
31.0
45
26
N05AX08
ATC
risperidone; systemic
15.0
30.5
53
50
N03AG01
ATC
valproic acid; systemic, rectal
14.4
29.9
53
52
F61.0
ICD-10 Finland
Mixed personality disorders
181.6
29.7
30
*
N06AB04
ATC
citalopram; systemic
7.4
29.6
90
228
F60.9
ICD-10 Finland
Personality disorder, unspecified
167.0
27.5
28
*
N05CD07
ATC
temazepam; oral
9.0
26.7
63
105
N06AX16
ATC
venlafaxine; oral
8.0
25.6
66
126
N05AB03
ATC
perphenazine; systemic, rectal
19.2
25.4
39
26
F32.9
ICD-10 Finland
Depressive episode, unspecified
8.9
24.8
58
94
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
20.3
24.6
37
23
N05BA04
ATC
oxazepam; oral
5.9
24.1
89
271
N06AB03
ATC
fluoxetine; oral
8.1
23.9
60
108
N03AE01
ATC
clonazepam; systemic
12.2
23.8
45
49
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
25.4
23.7
33
16
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
10.7
23.1
47
59
3015A
ICD-9 Finland
Personality disorders, Histrionic personality disorder[HUOMIONHAKUINEN PERSOONALLISUUS]
+∞
22.4
21
*
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
251.7
22.2
22
*
N05AN01
ATC
lithium; oral
25.8
21.7
30
14
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
24.8
20.8
29
14
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
13.3
20.7
37
35
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
21.2
20.5
30
17
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
11.0
19.8
39
45
N05AF03
ATC
chlorprothixene; systemic
26.5
19.8
27
12
F29
ICD-10 Finland
Unspecified nonorganic psychosis
14.4
18.8
32
27
N06AX11
ATC
mirtazapine; oral
4.6
18.7
92
353
N06AA09
ATC
amitriptyline; systemic
7.2
18.7
49
91
N03AX09
ATC
lamotrigine; oral
13.9
18.5
32
28
N04AA02
ATC
biperiden; systemic
27.8
17.9
24
10
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
8.2
17.8
42
66
N05BA06
ATC
lorazepam; systemic, sublingual
12.4
17.1
31
30
N05AX12
ATC
aripiprazole; systemic
15.1
16.4
27
21
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
15.9
15
*
P99
ICPC
Psychological disorders other
17.3
15.4
24
16
N06AX03
ATC
mianserin; oral
9.2
15.0
32
42
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
88.0
14.8
16
*
P29
ICPC
Psychological sympt/compl other
9.0
14.8
32
43
30010
ICD-8 Finland
Neuroses, Hysterical neurosis
+∞
14.8
14
*
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
40.0
14.8
18
5
F31.8
ICD-10 Finland
Other bipolar affective disorders
19.3
14.8
22
13
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
7.1
14.2
36
62
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
26.6
14.1
19
8
N03AX11
ATC
topiramate; oral
26.6
14.1
19
8
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.8
14.1
37
67
N02AX02
ATC
tramadol; systemic, rectal
3.6
13.9
100
491
N05BE01
ATC
buspirone; oral
15.6
13.7
22
16
N05AC02
ATC
thioridazine; oral
23.6
13.7
19
9
F34.1
ICD-10 Finland
Dysthymia
12.5
13.5
24
22
N06AB06
ATC
sertraline; oral
5.5
13.3
42
96
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
31.3
13.2
17
6
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
35.1
12.8
16
5
N05AD01
ATC
haloperidol; systemic
13.1
12.8
22
19
F60.5
ICD-10 Finland
Anankastic personality disorder
+∞
12.7
12
*
30180
ICD-8 Finland
Personality disorders, Immatura
+∞
12.7
12
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
17.7
12.5
19
12
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
32.7
11.9
15
5
N06AB10
ATC
escitalopram; oral
3.9
11.9
57
197
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
70.0
11.8
13
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.4
11.7
28
44
F60.8
ICD-10 Finland
Other specific personality disorders
+∞
11.6
11
*
F60.0
ICD-10 Finland
Paranoid personality disorder
+∞
11.6
11
*
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
37.9
11.5
14
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
37.9
11.5
14
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.8
11.4
41
107
N05CF01
ATC
zopiclone; oral
3.3
11.4
78
352
P72
ICPC
Schizophrenia
27.2
11.4
15
6
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
17.0
11.1
17
11
N05AD03
ATC
melperone; systemic
23.4
10.9
15
7
N06AA12
ATC
doxepin; systemic
7.0
10.9
27
45
N03AX16
ATC
pregabalin; oral
3.5
10.8
61
237
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
15.6
10.7
17
12
SPAT1240
SPAT
Therapeutic discussion
4.9
10.6
36
88
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
10.5
10
*
N07BB01
ATC
disulfiram; oral
8.9
10.5
22
28
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
35.0
10.5
13
*
N05AF05
ATC
zuclopenthixol; systemic
35.0
10.5
13
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
15.9
10.2
16
11
N05BA12
ATC
alprazolam; oral
4.6
10.1
37
98
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
42.8
10.1
12
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
18.1
10.1
15
9
N03AF02
ATC
oxcarbazepine; oral
10.6
10.1
19
20
30041
ICD-8 Finland
Neuroses, Depressiva
21.7
10.0
14
7
N05CD02
ATC
nitrazepam; oral
28.0
10.0
13
5
SPAT1254
SPAT
Administration of medicine
4.1
9.9
41
122
N05AB01
ATC
dixyrazine; systemic
32.1
9.5
12
*
M54.5
ICD-10 Finland
Low back pain
2.9
9.4
77
378
N06AA04
ATC
clomipramine; systemic
12.5
9.3
16
14
P01
ICPC
Feeling anxious/nervous/tense
4.5
9.3
34
90
F10.20
ICD-10 Finland
Alcohol dependence currently independent
39.0
9.1
11
*
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
25.7
9.0
12
5
F39
ICD-10 Finland
Unspecified mood [affective] disorder
15.1
8.9
14
10
F41.1
ICD-10 Finland
Generalized anxiety disorder
7.7
8.9
20
29
N02AA05
ATC
oxycodone; systemic
4.1
8.8
36
106
S06.0
ICD-10 Finland
Concussion
4.3
8.7
33
90
N06AB05
ATC
paroxetine; oral
6.7
8.5
21
35
R06.0
ICD-10 Finland
Dyspnoea
3.0
8.5
60
265
30199
ICD-8 Finland
Personality disorders, Unspecified
+∞
8.4
8
*
3015B
ICD-9 Finland
Personality disorders, Histrionic personality disorder[ITSEAIHEUTETTU HÄIRIÖ,RUUMIILLISIN OIREIN]
+∞
8.4
8
*
A28
ICPC
Limited function/disability NOS
3.9
8.3
35
105
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
15.5
8.3
13
9
N06AX12
ATC
bupropion; oral
7.0
8.3
20
32
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.8
8.2
23
45
N05AA01
ATC
chlorpromazine; systemic, rectal
35.2
8.2
10
*
P19
ICPC
Drug abuse
35.2
8.2
10
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.6
8.1
28
70
C07AA05
ATC
propranolol; systemic
3.1
7.9
50
205
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.3
7.8
20
35
N06AB08
ATC
fluvoxamine; oral
7.8
7.7
17
24
29999
ICD-8 Finland
Unspecified psychosis
26.4
7.7
10
*
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
26.4
7.7
10
*
D01AC02
ATC
miconazole; topical
4.5
7.6
27
69
N03AX12
ATC
gabapentin; oral
3.3
7.5
41
151
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
14.2
7.5
12
9
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
83.6
7.5
8
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
83.6
7.5
8
*
P18
ICPC
Medication abuse
83.6
7.5
8
*
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
83.6
7.5
8
*
N05AF01
ATC
flupentixol; systemic
11.6
7.4
13
12
F20.9
ICD-10 Finland
Schizophrenia, unspecified
11.6
7.4
13
12
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
3.3
7.3
40
147
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.7
7.3
33
105
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
+∞
7.3
7
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
+∞
7.3
7
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
16.7
7.3
11
7
N06AX21
ATC
duloxetine; oral
4.0
7.3
29
83
AA1AD
NOMESCO Finland
CT of head and brain
2.9
7.3
50
216
P80
ICPC
Personality disorder
31.5
7.2
9
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
31.5
7.2
9
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
31.5
7.2
9
*
E000001
ATC
NA
2.9
7.1
48
202
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
14.6
7.0
11
8
N06AX22
ATC
agomelatine; oral
14.6
7.0
11
8
N06AG02
ATC
moclobemide; oral
6.6
7.0
17
28
A06AD11
ATC
lactulose; oral
3.5
6.9
33
110
F40.1
ICD-10 Finland
Social phobias
17.6
6.8
10
6
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
6.4
6.8
17
29
N06AX26
ATC
vortioxetine; oral
6.4
6.8
17
29
G04BD04
ATC
oxybutynin; oral, transdermal
5.5
6.7
19
38
L28
ICPC
Limited function/disability (L)
3.1
6.7
38
144
Z71.8
ICD-10 Finland
Other specified counselling
2.6
6.7
54
256
SPAT1234
SPAT
Support of social functional capacity
6.2
6.7
17
30
NA1AD
NOMESCO Finland
Cervical spine CT examination
7.1
6.5
15
23
F51.0
ICD-10 Finland
Nonorganic insomnia
3.2
6.5
35
126
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
15.1
6.5
10
7
N05AH02
ATC
clozapine; systemic
15.1
6.5
10
7
SPAT1307
SPAT
Psychosocial counselling and guidance
4.7
6.4
21
50
N89
ICPC
Migraine
11.7
6.4
11
10
V03AA01
ATC
NA
18.9
6.3
9
5
R53
ICD-10 Finland
Malaise and fatigue
2.8
6.3
45
197
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
6.3
52
248
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
+∞
6.3
6
*
79020
ICD-8 Finland
Nervousness and debility, Depression
+∞
6.3
6
*
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
+∞
6.3
6
*
34598
ICD-8 Finland
Epilepsy, Alia definita
+∞
6.3
6
*
3001A
ICD-9 Finland
Neurotic disorders, Hysteria[KONVERSIOHÄIRIÖ]
+∞
6.3
6
*
M01AG02
ATC
tolfenamic acid; oral, rectal
3.0
6.2
38
151
R29
ICPC
Respiratory symptom/complaint other
4.7
6.2
20
47
R41.0
ICD-10 Finland
Disorientation, unspecified
9.1
6.2
12
14
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
13.2
6.2
10
8
F41.8
ICD-10 Finland
Other specified anxiety disorders
13.2
6.2
10
8
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
13.2
6.2
10
8
P74
ICPC
Anxiety disorder/anxiety state
6.5
6.2
15
25
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
6.1
33
118
R05
ICPC
Cough
2.6
6.1
51
245
R02
ICPC
Shortness of breath/dyspnoea
3.3
6.1
30
103
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.8
6.0
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011288) Drugs identified in Urine by Screen method
30
29
12.21
27.89
3.9
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
23
18
14.50
24.18
2.9
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
27
35
8.90
20.12
3.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
45
7.80
19.80
3.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
45
7.80
19.80
3.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
46
7.63
19.41
3.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
46
7.63
19.41
3.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
28
47
6.87
16.61
3.0
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
132
853
3.05
10.27
5.5
4.1
mmol/l
6.4
6.6
0.34
125
787
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
87
454
2.77
10.23
3.2
2.3
u/l
58.0
58.1
0.00
81
427
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
12
5
25.54
9.03
16.7
5.2
mmol/l
0.6
0.6
—
12
5
(3021960) Folate [Moles/volume] in Serum or Plasma
67
331
2.63
8.48
1.4
1.5
nmol/l
18.1
22.5
1.40
57
273
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
79
425
2.53
8.35
2.7
2.0
u/l
138.1
147.3
0.18
73
407
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
111
700
2.53
8.30
5.0
6.3
mmol/l
1.2
1.2
0.56
95
606
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
94
563
2.40
7.69
2.3
1.9
pmol/l
93.6
99.3
0.44
49
262
(3019060) Gas panel - Arterial blood
27
85
3.56
7.47
3.2
4.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
84
488
2.35
7.26
4.1
3.2
u/l
31.0
28.7
0.23
77
461
(3019150) Specific gravity of Urine by Refractometry
64
333
2.43
7.06
5.4
3.6
kg/l
1.0
1.0
—
6
39
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
116
782
2.36
6.98
5.0
6.2
umol/l
10.1
10.2
0.03
106
748
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
89
537
2.30
6.96
5.7
3.3
ng/l
54.1
35.8
0.28
65
350
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
149
1130
2.85
6.86
7.9
7.5
u/l
86.0
76.4
0.99
142
1060
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
100
643
2.25
6.61
5.2
5.2
mmol/l
1.2
1.2
0.48
91
589
(3023368) Bacteria identified in Blood by Culture
67
365
2.33
6.59
5.0
4.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
55
275
2.44
6.56
1.9
1.7
pmol/l
434.0
461.5
0.33
44
236
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
36
146
2.83
6.54
3.3
6.6
kpa
5.3
5.1
0.50
36
141
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
322
2.35
6.43
2.0
1.7
mg/l
0.8
1.0
0.92
45
253
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
62
332
2.32
6.31
1.7
2.0
mg/l
2.9
3.4
0.60
49
286
(3009508) Creatinine [Moles/volume] in Urine
74
428
2.24
6.26
3.5
3.0
mmol/l
6.4
7.6
1.73
62
355
(3022217) INR in Platelet poor plasma by Coagulation assay
38
165
2.65
6.04
18.1
18.8
inr
1.1
1.3
—
6
25
(3024561) Albumin [Mass/volume] in Serum or Plasma
95
618
2.14
5.87
4.4
4.2
g/l
35.1
36.0
0.80
86
584
(3003396) Base excess in Arterial blood by calculation
35
148
2.69
5.85
3.2
6.6
mmol/l
1.9
1.5
0.32
27
116
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
98
648
2.12
5.77
2.4
2.3
nmol/l
71.8
77.5
1.19
87
573
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
218
2.42
5.68
2.2
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
95
3.03
5.65
1.7
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
77
473
2.10
5.43
3.8
5.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
47
239
2.31
5.29
2.4
1.6
nmol/l
1097.4
1229.7
0.50
35
176
(3021447) Carbon dioxide [Partial pressure] in Venous blood
30
125
2.68
5.14
3.2
3.0
kpa
6.1
5.7
1.33
30
125
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
152
2.52
5.06
2.2
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
22
79
3.03
4.92
3.1
2.4
mmol/l
25.6
25.0
0.38
22
79
(3000991) Gas panel - Venous blood
25
97
2.83
4.88
3.4
6.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
27
111
2.69
4.74
3.4
2.4
ug/l
7.2
4.9
0.19
21
98
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
81
2.95
4.71
1.5
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
29
4.36
4.70
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
152
2.43
4.60
2.2
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
133
1037
2.08
4.49
5.3
2.8
u/l
58.8
44.5
0.89
122
980
(3026008) Bacteria identified in Urine by Culture
72
459
1.95
4.38
6.2
2.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
43
227
2.17
4.37
2.1
3.1
mmol/l
0.8
0.8
0.91
36
214
(3012544) pH of Venous blood
29
130
2.47
4.27
3.3
3.0
—
—
—
0
0
(3020891) Body temperature
17
57
3.19
4.25
6.9
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
124
2.49
4.23
3.6
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
143
1167
2.10
3.96
6.2
4.0
pmol/l
14.6
14.7
0.26
134
1056
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
62
388
1.91
3.91
3.3
2.9
ng/l
570.9
1144.0
1.76
49
328
(3037467) Urinalysis macro (dipstick) panel - Urine
131
1040
1.95
3.88
7.0
4.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
8
12
6.92
3.71
13.0
21.8
nmol/l
1355.1
1291.7
—
8
12
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
525
1.82
3.67
4.3
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
182
2.15
3.66
9.2
6.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
24
106
2.46
3.64
3.3
2.5
kpa
4.2
4.4
0.18
24
106
(3013512) EKG study
64
413
1.85
3.63
5.8
3.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19
75
2.71
3.60
4.2
3.0
%
48.8
48.6
0.01
19
75
(3013650) Neutrophils [#/volume] in Blood by Automated count
112
858
1.81
3.58
10.2
10.0
e9/l
4.4
4.0
0.98
97
761
(3019069) Monocytes/100 leukocytes in Blood
94
692
1.75
3.37
5.1
6.0
%
8.0
8.3
0.38
85
647
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
20
84
2.55
3.37
4.0
6.8
%
0.7
0.7
0.15
20
84
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
20
84
2.55
3.37
4.0
6.8
%
2.6
1.3
2.16
20
84
(3002030) Lymphocytes/100 leukocytes in Blood
95
706
1.73
3.26
5.2
5.8
%
28.6
28.4
0.05
86
656
(3006504) Eosinophils/100 leukocytes in Blood
93
688
1.73
3.23
4.9
5.6
%
2.7
2.8
0.02
84
638
(3026782) Osmolality of Urine
47
284
1.89
3.23
4.0
2.6
mosm/kgh2o
502.3
569.6
1.02
39
239
(3013707) Erythrocyte sedimentation rate by Westergren method
137
1134
1.87
3.20
4.0
4.1
mm/h
12.3
10.9
0.70
122
1043
(3022096) Basophils/100 leukocytes in Blood
90
662
1.72
3.18
5.1
5.7
%
0.7
0.7
0.10
80
613
(3013115) Eosinophils [#/volume] in Blood
100
760
1.71
3.11
5.6
5.9
e9/l
0.2
0.2
0.17
83
673
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
18
75
2.56
3.08
2.7
3.1
kpa
5.2
5.2
0.09
18
67
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
8
7.71
3.08
1.5
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
159
1393
2.21
3.02
7.6
4.7
mu/l
1.7
1.9
1.71
147
1274
(3018010) Neutrophils/100 leukocytes in Blood
93
699
1.68
2.97
4.6
5.5
%
56.7
57.0
0.09
84
654
(3032080) INR in Blood by Coagulation assay
77
555
1.68
2.85
12.5
7.4
inr
1.2
1.2
0.06
30
155
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
164
2.00
2.74
2.3
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
64
444
1.68
2.71
2.7
3.8
ph
7.4
7.4
0.15
13
78
(3015377) Calcium [Moles/volume] in Serum or Plasma
70
498
1.66
2.69
2.4
3.2
mmol/l
2.4
2.4
0.07
59
438
(3001604) Monocytes [#/volume] in Blood
95
734
1.62
2.61
5.3
5.7
e9/l
0.6
0.6
0.57
83
637
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
20
4.13
2.60
2.0
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
41
255
1.79
2.54
6.0
3.1
ng/l
12.7
139.0
2.00
27
191
(3006315) Basophils [#/volume] in Blood
95
738
1.61
2.53
5.6
5.7
e9/l
0.0
0.0
0.29
83
639
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
157
1393
1.99
2.51
7.4
5.4
mmol/mol
39.4
39.4
0.01
143
1306
(3029937) Albumin [Presence] in Urine by Test strip
58
400
1.66
2.49
6.7
3.6
estimate
0.0
0.0
0.00
20
130
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
140
2.00
2.48
5.2
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
73
535
1.61
2.46
4.8
3.4
e6/l
99.3
56.8
0.63
55
357
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
27
3.45
2.43
2.1
2.6
mmol/l
26.6
25.2
—
9
21
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
31
179
1.88
2.42
2.7
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
342
1.69
2.42
1.5
1.2
u/ml
0.5
1.0
1.22
15
90
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
12
5.13
2.42
12.5
14.3
nmol/l
852.2
771.5
—
6
12
(3019198) Lymphocytes [#/volume] in Blood
96
755
1.58
2.38
5.6
5.6
e9/l
2.0
2.0
0.15
86
668
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
174
1.87
2.31
2.0
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
20
102
2.08
2.20
2.8
3.1
e9/l
62.3
70.5
0.54
13
76
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
162
0.35
2.15
1.2
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
126
1.95
2.10
1.1
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
35
220
1.73
2.08
1.9
2.1
umol/l
12.1
13.2
0.41
29
207
(3019225) pH of Specimen
24
134
1.91
2.08
4.0
4.3
—
—
—
0
0
(4010399)
21
112
1.99
2.06
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
164
1502
2.03
2.00
21.8
12.9
mg/l
21.7
21.8
0.01
143
1165
(21494755) Public health laboratory ask at order entry panel
6
159
0.36
2.00
1.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
31
191
1.75
1.98
1.6
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
57
412
1.56
1.97
3.8
2.9
e6/l
0.3
0.4
0.45
48
298
(4146454)
6
16
3.84
1.95
2.3
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
50
352
1.58
1.93
6.2
3.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
58
423
1.55
1.92
4.2
4.0
mg/mmol
15.0
9.9
0.24
34
268
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
22
3.27
1.90
1.4
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
12
53
2.35
1.85
1.1
1.4
—
1.9
—
0
5
(3007853) Bacteria identified in Skin by Aerobe culture
27
163
1.77
1.84
1.5
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
21
117
1.90
1.84
1.9
3.2
ng/l
56.1
70.6
0.86
16
102
(3021589) Normoblasts [#/volume] in Blood
82
649
1.48
1.83
8.5
9.3
e9/l
0.0
0.0
0.30
68
531
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
35
2.65
1.83
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
23
3.12
1.82
1.1
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
41
571
0.63
1.78
2.7
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
55
406
1.51
1.70
3.6
2.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
30
192
1.68
1.68
2.1
2.1
%
18.6
22.4
0.95
24
174
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
43
2.40
1.63
1.6
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
14
3.64
1.62
1.8
2.2
%
92.8
89.1
—
5
14
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
57
2.18
1.59
2.1
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
108
1.85
1.58
2.7
2.4
ml/min/173m2
83.5
63.8
—
10
44
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
289
1.54
1.56
2.2
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
79
1.98
1.54
2.0
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
21
2.92
1.52
1.0
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
62
479
1.45
1.51
1.9
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
87
1.92
1.51
1.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
87
716
1.42
1.50
4.6
3.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
37
2.51
1.50
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
30
198
1.62
1.50
1.9
2.1
g/l
2.4
2.4
0.11
23
184
(42529406) Shigella sp [Presence] in Stool by Culture
10
45
2.29
1.49
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
45
2.29
1.49
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
45
2.29
1.49
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
52
2.19
1.47
2.5
2.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
74
1.97
1.43
4.2
2.1
%
1.6
1.4
0.32
14
74
(3012516) Albumin [Mass/volume] in Urine
53
402
1.45
1.41
3.5
3.2
mg/l
1421.2
59.6
0.49
34
259
(3026493) Urate [Moles/volume] in Serum or Plasma
51
384
1.46
1.41
2.3
2.6
umol/l
340.4
7563.6
2.27
46
333
(3042936) Bacteria identified in Isolate by Culture
32
219
1.56
1.38
2.1
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
58
450
1.43
1.37
4.5
2.9
e6/l
168.7
62.4
0.57
50
336
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
54
2.10
1.36
1.8
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
54
2.10
1.36
3.1
3.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
39
0.00
1.35
0.0
3.6
—
39.3
—
0
39
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
188
1.58
1.31
4.6
4.1
%
30.2
32.3
0.51
16
118
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
62
2.00
1.31
3.2
6.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
26
172
1.60
1.30
1.7
2.5
umol/l
4.4
6.2
1.01
19
150
(3007164) IgA [Mass/volume] in Serum or Plasma
43
319
1.46
1.28
1.5
1.4
g/l
2.0
2.3
0.92
28
191
(3025941) Bacteria identified in Stool by Culture
15
85
1.83
1.27
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
89
751
1.37
1.26
6.2
3.5
estimate
0.0
0.0
0.00
18
137
(3048689) Calprotectin [Mass/mass] in Stool
28
190
1.56
1.26
2.7
2.3
ug/g
75.3
144.8
1.14
19
146
(3021440) Promyelocytes/100 leukocytes in Blood
19
118
1.68
1.20
2.5
4.7
%
0.0
0.2
—
5
34
(3001122) Ferritin [Mass/volume] in Serum or Plasma
81
678
1.35
1.19
3.1
2.5
ug/l
93.1
93.8
0.01
70
631
(40758558) Short blood count panel - Blood
48
369
1.41
1.18
7.5
7.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
18
111
1.69
1.17
1.3
2.5
g/l
67.2
67.0
0.04
13
100
(3008037) Lactate [Moles/volume] in Venous blood
8
39
2.10
1.17
2.4
2.3
mmol/l
1.4
1.4
—
8
39
(3025130) Human papilloma virus identified in Specimen
0
35
0.00
1.16
0.0
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
22
144
1.60
1.15
2.0
3.0
%
1.9
1.8
0.05
17
132
(3017181) Myelocytes/100 leukocytes in Blood
20
128
1.63
1.14
2.4
4.5
%
0.7
1.0
—
6
41
(3017732) Neutrophils [#/volume] in Blood
16
97
1.71
1.11
1.4
2.3
e9/l
4.5
3.9
0.32
11
75
(3009261) Glucose [Presence] in Urine by Test strip
89
762
1.33
1.10
7.2
3.5
estimate
0.0
0.0
0.00
19
128
(3021901) Oxygen saturation in Capillary blood
5
21
2.42
1.10
1.8
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
358
1.38
1.05
2.0
2.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
168
1601
1.74
1.04
24.0
14.6
umol/l
74.3
73.0
0.18
168
1601
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
50
1.84
0.98
2.3
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
156
1467
1.48
0.98
5.6
4.3
mmol/l
6.0
5.9
0.70
140
1346
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
27
2.26
0.94
5.5
3.8
e9/l
4.4
4.5
—
6
27
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
27
2.26
0.94
5.3
4.6
%
57.0
60.8
—
6
27
(3003327) Ova and parasites identified in Stool by Light microscopy
9
52
1.77
0.94
1.3
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
28
2.18
0.92
3.2
2.3
kpa
5.9
5.3
—
6
28
(3027315) Oxygen [Partial pressure] in Blood
6
28
2.18
0.92
3.2
2.3
kpa
8.7
8.6
—
6
28
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
249
1.40
0.90
3.0
2.6
e6/l
1.9
1.1
0.59
24
137
(3021601) Nitrite [Presence] in Urine by Test strip
87
759
1.28
0.89
8.8
4.9
estimate
0.0
0.0
0.00
20
135
(3000492) Spirometry study
8
137
0.56
0.87
1.3
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
31
1.97
0.85
1.2
1.2
—
53.5
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
31
1.97
0.85
1.2
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
113
1024
1.28
0.83
4.7
3.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
47
1.73
0.82
3.5
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
11
174
0.61
0.81
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
66
1.71
0.80
1.5
1.8
mg/l
3.6
2.4
0.33
11
46
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
74
1.67
0.80
3.2
4.7
mmol/l
27.5
25.6
0.36
12
74
(3044290) Cell count panel - Cerebral spinal fluid
6
33
1.85
0.80
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
26
0.00
0.79
0.0
1.4
—
7.5
—
0
17
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
84
1.59
0.74
2.3
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
44
359
1.30
0.74
5.8
5.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
39
1.83
0.73
2.0
2.3
mmol/l
6.7
6.8
—
7
39
(40768793) Breast Pathology biopsy report
9
57
1.61
0.72
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
40
1.78
0.72
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
9
58
1.58
0.71
1.8
1.8
ug/l
8.1
6.8
—
9
51
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
58
1.58
0.71
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
68
589
1.25
0.71
7.5
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
41
1.74
0.71
2.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
150
1422
1.33
0.69
18.6
11.8
ml/min/173m2
84.6
83.0
0.35
129
1147
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
27
1.88
0.69
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
27
1.88
0.69
1.6
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
124
1324
0.80
0.68
30.3
16.2
g/l
331.5
332.1
0.34
124
1318
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
104
1.48
0.65
2.4
1.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
3.8
—
90.3
—
0
20
(3022145) Colonoscopy Study observation
13
183
0.69
0.59
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
171
0.68
0.58
1.8
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
60
1.53
0.55
1.1
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
61
1.50
0.54
5.8
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
16
117
1.40
0.54
5.8
3.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
62
1.48
0.54
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
225
1.29
0.53
4.1
2.8
e6/l
3.2
3.4
0.07
20
117
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
156
1502
1.29
0.51
4.6
4.2
mmol/l
4.6
4.7
0.62
139
1401
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
166
1612
1.38
0.50
13.3
10.1
u/l
24.8
25.5
0.25
156
1561
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
49
1.45
0.46
1.0
1.1
—
10.8
—
0
8
(3004588) Protein electrophoresis panel - Serum or Plasma
13
95
1.40
0.45
1.5
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
307
1.22
0.43
1.8
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
32
1.58
0.42
8.2
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
196
1.26
0.42
1.6
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
79
1.42
0.42
6.5
3.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
1.2
—
0
8
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
158
1532
1.26
0.41
5.2
4.7
mmol/l
2.8
2.8
0.07
140
1417
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
320
0.82
0.39
1.3
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.6
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
57
628
0.86
0.36
1.9
2.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
134
1391
0.86
0.35
20.5
13.4
%
36.6
40.1
1.90
80
1044
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
249
1.20
0.33
1.9
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
149
1444
1.18
0.33
4.0
3.8
mmol/l
1.5
1.3
2.54
128
1338
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
83
1.35
0.33
1.2
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
47
1.29
0.32
1.5
2.9
—
—
—
0
0
(4034850)
7
53
1.33
0.31
13.1
10.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
57
1.24
0.29
2.0
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
153
1495
1.16
0.24
4.5
4.2
mmol/l
1.4
1.5
1.80
135
1386
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
105
1006
1.10
0.24
3.6
3.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
41
1.23
0.22
1.0
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
42
1.20
0.21
1.4
3.5
mg/l
46.9
39.9
—
5
35
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
42
1.20
0.21
1.4
3.5
mg/l
38.6
27.3
—
5
35
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.8
—
11.6
—
0
10
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
0.1
—
0
6
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
279
1.13
0.21
1.1
1.3
u/ml
1.6
10.8
2.86
13
115
(3015183) Erythrocyte sedimentation rate
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
14
0.00
0.20
0.0
1.6
—
6.6
—
0
7
(21494890) Protein electrophoresis panel - 24 hour Urine
0
14
0.00
0.20
0.0
3.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
99
1.23
0.20
1.3
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
68
0.73
0.17
2.0
2.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
117
0.85
0.13
1.6
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
291
1.08
0.10
1.2
1.3
iu/ml
12.1
33.6
—
10
98
(1761482) Bacteria [#/volume] in Urine by Culture
5
44
1.14
0.10
6.4
4.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
41
429
0.94
0.09
1.6
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
61
0.81
0.08
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
40
418
0.94
0.08
6.7
3.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
244
0.93
0.07
4.3
4.0
%
26.9
20.9
0.89
13
114
(40761511) CBC panel - Blood by Automated count
161
1597
1.08
0.06
23.5
11.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
42
405
1.05
0.06
1.6
1.6
mmol/l
1.3
1.3
0.00
33
352
(3019832) Treponema pallidum Ab [Presence] in Serum
16
159
1.01
0.00
2.0
1.7
—
—
—
0
0
(4035726)
13
135
0.96
0.00
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
95
1.06
0.00
9.7
2.8
—
—
—
0
0
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.8
—
202.9
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
0.9
—
0
9
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
3.2
—
0
9
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
6
0.00
0.00
0.0
32.8
—
77.8
—
0
6
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
30.0
—
0
9
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
99.4
—
0
9
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.9
—
16.8
—
0
8
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
5.9
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_HISPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_HISPER | 3.111 [2.32, 4.18] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.171 |
During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 395 females with F5_HISPER died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have F5_HISPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.352% | No data |
| 5 | 1.577% | No data |
| 10 | 4.391% | No data |
| 15 | 7.889% | No data |
| 20 | 13.936% | No data |
Relationships between endpoints
↥Index endpoint: F5_HISPER – Histrionic personality disorder
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data